id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0436-0026,FDA,FDA-2011-D-0436,International Conference on Harmonisation; Guidance Availability: Q11 Development and Manufacture of Drug Substances,Notice,Notice of Availability,2012-11-20T05:00:00Z,2012,11,2012-11-20T05:00:00Z,,2012-11-20T15:21:44Z,2012-28142,0,0,090000648116e95a